Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients&...

Full description

Bibliographic Details
Main Authors: Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Neuropsychiatric Disease and Treatment
Online Access:https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDT

Similar Items